Boston University’s National Emerging Infectious Diseases Laboratories Appoints Facilities Director
Charles (Chuck) N. Pantinas has joined the National Emerging Infectious Diseases Laboratories (NEIDL) as the facilities core director. In this role, Pantinas is responsible for the creation, maintenance and oversight of engineering standards and the ongoing design and commissioning of the NEIDL. In addition, Pantinas is tasked with continuing the development and implementation of network-wide standards and procedures. Pantinas’ primary function is focused on continued safe operation of the facility.
“We are pleased to have Chuck join our team as his experience lends itself quite well to NEIDL operations,” said John Murphy, PhD, interim NEIDL director. “Chuck will implement processes within the facility that will ensure continued safety and productivity.”
Prior to his appointment, Pantinas served as a Lean Leader and Business Leader in Facilities and Technical Services leader within the aviation branch of General Electric. In these roles, he led optimization programs to improve productivity, flexibility and business processes in the plant service organization. He also directed the facilities and manufacturing engineering services group at GE Aviation’s Lynn River Works facility. Before his work at GE, Pantinas was a Group Manager of Facilities Services’ for more than 6 years at Procter and Gamble Company.
Pantinas holds a Master of Science in Engineering Management from Northeastern University and a Bachelor of Science in Marine Engineering from the Massachusetts Maritime Academy.
The National Emerging Infectious Diseases Laboratories is part of a national network of secure facilities studying infectious diseases that are—or have the potential to become—major public health concerns. The laboratories are dedicated to the development of diagnostics, vaccines, and treatments to combat emerging and re-emerging infectious diseases. The NEIDL adds to the growing life sciences industry in the region, throughout the Commonwealth of Massachusetts, and across the country.
Boston University’s National Emerging Infectious Diseases Laboratories (NEIDL) is part of a national network of secure facilities studying infectious diseases that are—or have the potential to become—major public health concerns. The 192,000-square-foot, seven-story facility, located on the Boston University Medical Campus, houses BSL-2, BSL-3 and BSL-4 laboratories dedicated to the development of diagnostics, vaccines, and treatments to combat emerging and re-emerging infectious diseases. Using state-of-the-art technologies developed to conduct research in safe and secure environments, the facility was designed and constructed with the highest attention to community and laboratory safety and security.